BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 3097327)

  • 1. Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A.
    Satow Y; Cohen GH; Padlan EA; Davies DR
    J Mol Biol; 1986 Aug; 190(4):593-604. PubMed ID: 3097327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the specificity of antibody/antigen interactions: phosphocholine binding to McPC603 and the correlation of three-dimensional structure and sequence data.
    Padlan EA; Cohen GH; Davies DR
    Ann Inst Pasteur Immunol (1985); 1985; 136C(2):271-6. PubMed ID: 3890687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The galactan-binding immunoglobulin Fab J539: an X-ray diffraction study at 2.6-A resolution.
    Suh SW; Bhat TN; Navia MA; Cohen GH; Rao DN; Rudikoff S; Davies DR
    Proteins; 1986 Sep; 1(1):74-80. PubMed ID: 3449853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site.
    Segal DM; Padlan EA; Cohen GH; Rudikoff S; Potter M; Davies DR
    Proc Natl Acad Sci U S A; 1974 Nov; 71(11):4298-302. PubMed ID: 4530984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type 1.
    He XM; Rüker F; Casale E; Carter DC
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7154-8. PubMed ID: 1496010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and transmitted conformational changes on complexation of an anti-sweetener Fab.
    Guddat LW; Shan L; Anchin JM; Linthicum DS; Edmundson AB
    J Mol Biol; 1994 Feb; 236(1):247-74. PubMed ID: 7893280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human and murine phosphorycholine-binding immunoglobulins: conserved subgroup and first hypervariable region of heavy chains.
    Riesen WF; Braun DG; Jaton JC
    Proc Natl Acad Sci U S A; 1976 Jun; 73(6):2096-100. PubMed ID: 819931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An autoantibody to single-stranded DNA: comparison of the three-dimensional structures of the unliganded Fab and a deoxynucleotide-Fab complex.
    Herron JN; He XM; Ballard DW; Blier PR; Pace PE; Bothwell AL; Voss EW; Edmundson AB
    Proteins; 1991; 11(3):159-75. PubMed ID: 1749770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the antigen-binding fragment of the murine anti-arsonate monoclonal antibody 36-71 at 2.9-A resolution.
    Rose DR; Strong RK; Margolies MN; Gefter ML; Petsko GA
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):338-42. PubMed ID: 2296590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function relations in phosphorylcholine-binding mouse myeloma proteins.
    Goetze AM; Richards JH
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2109-12. PubMed ID: 405672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex.
    Tulip WR; Varghese JN; Laver WG; Webster RG; Colman PM
    J Mol Biol; 1992 Sep; 227(1):122-48. PubMed ID: 1381757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2.
    Tormo J; Stadler E; Skern T; Auer H; Kanzler O; Betzel C; Blaas D; Fita I
    Protein Sci; 1992 Sep; 1(9):1154-61. PubMed ID: 1338980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
    Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
    J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of phosphorylcholine binding to antibodies using synthetic peptides.
    Lai EH; Kabat EA; Meienhofer J; Heimer EP; Olson AJ; Lerner R
    Nature; 1987 Jan 8-14; 325(7000):168-71. PubMed ID: 3808074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combined proton and phosphorus-31 nuclear magnetic resonance investigation of the combining site of M603, a phosphocholine-binding myeloma protein.
    Gettins P; Pótter M; Leatherbarrow RJ; Dwek RA
    Biochemistry; 1982 Sep; 21(20):4927-31. PubMed ID: 6291593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional structure of murine anti-p-azophenylarsonate Fab 36-71. 1. X-ray crystallography, site-directed mutagenesis, and modeling of the complex with hapten.
    Strong RK; Campbell R; Rose DR; Petsko GA; Sharon J; Margolies MN
    Biochemistry; 1991 Apr; 30(15):3739-48. PubMed ID: 2015229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
    Li Y; Li H; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the mimicry of polysaccharide antigens by anti-idiotypic antibodies. The crystallization, molecular replacement, and refinement to 2.8 A resolution of an idiotope-anti-idiotope Fab complex and of the unliganded anti-idiotope Fab.
    Evans SV; Rose DR; To R; Young NM; Bundle DR
    J Mol Biol; 1994 Sep; 241(5):691-705. PubMed ID: 8071993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of galactan-binding mouse immunoglobulin J539 Fab at 4.5-A resolution.
    Navia MA; Segal DM; Padlan EA; Davies DR; Rao N; Rudikoff S; Potter M
    Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4071-4. PubMed ID: 291062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystals of phosphorylcholine-binding Fab-fragments from mouse myeloma proteins: preparation and x-ray analysis.
    Rudikoff S; Potter M; Segal DM; Padlan EA; Davies DR
    Proc Natl Acad Sci U S A; 1972 Dec; 69(12):3689-92. PubMed ID: 4566456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.